These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 15721633

  • 1. Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.
    Rousseau-Merck MF, Fiette L, Klochendler-Yeivin A, Delattre O, Aurias A.
    Cancer Genet Cytogenet; 2005 Mar; 157(2):127-33. PubMed ID: 15721633
    [Abstract] [Full Text] [Related]

  • 2. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A.
    Cancer Res; 1999 Jul 01; 59(13):3152-6. PubMed ID: 10397258
    [Abstract] [Full Text] [Related]

  • 3. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB.
    Clin Cancer Res; 2002 Nov 01; 8(11):3461-7. PubMed ID: 12429635
    [Abstract] [Full Text] [Related]

  • 4. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M.
    Genes Chromosomes Cancer; 2004 Jun 01; 40(2):133-9. PubMed ID: 15101046
    [Abstract] [Full Text] [Related]

  • 5. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA.
    Clin Cancer Res; 2009 Mar 15; 15(6):1923-30. PubMed ID: 19276269
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B.
    Cancer Res; 1999 Jan 01; 59(1):74-9. PubMed ID: 9892189
    [Abstract] [Full Text] [Related]

  • 9. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
    Bahrami A, Lee S, Caradine KD, Raimondi SC, Folpe AL.
    Cancer Genet; 2014 Sep 01; 207(9):437-40. PubMed ID: 25312828
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA.
    Neurosurg Focus; 2006 Jan 15; 20(1):E11. PubMed ID: 16459991
    [Abstract] [Full Text] [Related]

  • 11. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, Pierron G, Sainte-Rose C, Bergeron C, Bouvier R, Rialland X, Laurence V, Michon J, Sastre-Garau X, Delattre O.
    J Pathol; 2007 Feb 15; 211(3):323-30. PubMed ID: 17152049
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
    Fujisawa H, Takabatake Y, Fukusato T, Tachibana O, Tsuchiya Y, Yamashita J.
    J Neurooncol; 2003 Jul 15; 63(3):257-62. PubMed ID: 12892231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB.
    Genes Chromosomes Cancer; 2000 May 15; 28(1):31-7. PubMed ID: 10738300
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
    Tsikitis M, Zhang Z, Edelman W, Zagzag D, Kalpana GV.
    Proc Natl Acad Sci U S A; 2005 Aug 23; 102(34):12129-34. PubMed ID: 16099835
    [Abstract] [Full Text] [Related]

  • 19. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
    Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T.
    Cancer Genet Cytogenet; 2005 Apr 15; 158(2):172-9. PubMed ID: 15796965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.